 survival thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Clinical experience patients BACKGROUND AND METHODS Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome TTP-HUS microangiopathic hemolytic anemia thrombocytopenia central nervous system abnormalities renal dysfunction early reports mortality percent treatment protocol patients Johns Hopkins Hospital diagnosis TTP-HUS Treatment mg prednisone day patients minimal symptoms central nervous system symptoms prednisone plasma exchange patients rapid clinical deterioration hours prednisone patients central nervous system symptoms hematocrit values platelet counts RESULTS total patients percent effective patients mild TTP-HUS relapses deaths Plasma exchange prednisone patients complicated TTP-HUS relapses deaths Relapses patients maintenance plasma infusions splenectomy treatment aspirin dipyridamole effective poor response exchange None patients positive cultures Escherichia coli Nine percent patients pregnant none birth infants TTP-HUS CONCLUSIONS Effective treatment percent survival available patients TTP-HUS